A detailed history of Capital Advisors, Ltd. LLC transactions in Natera, Inc. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 19 shares of NTRA stock, worth $3,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 19 -0.0%
Holding current value
$3,195
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$85.28 - $112.6 $341 - $450
4 Added 26.67%
19 $2,000
Q4 2022

Feb 07, 2023

SELL
$34.17 - $47.91 $1,366 - $1,916
-40 Reduced 72.73%
15 $1,000
Q3 2022

Nov 09, 2022

BUY
$36.93 - $56.68 $1,477 - $2,267
40 Added 266.67%
55 $2,000
Q2 2022

Aug 05, 2022

BUY
$28.13 - $44.54 $421 - $668
15 New
15 $1,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.